ecancermedicalscience

Conference Report

Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials

8 Dec 2014
Linda Cairns

Chemoprevention or the now more preferred ‘cancer prevention’ is the long-term administration of a biological or chemical agent to reduce the risk of cancer. This approach has long been active in individuals at high risk of developing breast or colon cancer. The aim of this expert meeting was to review the current status of the field of cancer prevention and potential, emerging biomarkers specifically focusing on breast, colon, and lung cancer but also with sessions on ovary and prostate.

Related Articles

Ashutosh Mishra, Amit Kumar, Ajay Gogia, Chinmay Bagla, Gajendra Pandit, Jyoti Sharma, Jyoutishman Saikia, Rohan Kapoor, D N Sharma, Atul Batra, Surendra Saini, Supriya Mallick, Nishkarsh Gupta, Brajesh Ratre, Ruchi Rathore, Sandeep Mathur, Sunil Kumar, Suryanarayana Deo
Imad Barjij, Sarah Naciri, Sihame Lkhoyaali, Saoussane Kharmoum, Hanane Inrhaouen, Ibrahim Elghissassi, Saber Boutayeb, Hind Mrabti, Hassan Errihani
Moushumi Suryavanshi, Prashant Mehta, Manoj Kumar, Saphalta Bhagmar, Vidit Kapoor, Dushyant Kumar, Sweta Mishra, Bhawna Chauhan
Maria Lucila González Donna, Eliza Ramirez Cabrera, Andrea Magali del Valle Ochelli, Lucia Ayala Albertini, Lucas Coradini, Verónica Alejandra Livieres Alayón, Iván Garrigoza Garcete, Cinthia Gauna Colas, Maria Luisa Cabañas León, Jabibi Noguera, Gladys Estigarribia, Alejandro Frydman, Carlos Palmes, Santiago Leguizamon, Matias Rodrigo Chacon, Federico Waisberg